2 Eaton SB, Konner M (1985) Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med 312: 283-9.

3 Jeffery RW, Harnack LJ (2007) Evidence implicating eating as a primary driver for the obesity epidemic. Diabetes 56: 2673-6.

4 Huttunen JK, Manninen V, Mänttäri M, Koskinen P, Romo M, et al. (1991) The Helsinki Heart Study: central findings and clinical implications. Ann Med 23: 155-9.

6 Food and Agriculture Organization of the United Nations (FAOSTAT) FAO Statistics Division 2010, Food Balance Sheets, Rome, Italy.

7 Kushi LH, Byers T, Doyle C, Bandera EV, McCullough M, et al. (2006) American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 56: 254-81.

8 U.S. Departments of Agriculture (USDA) Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010, USA.

9 United States Department of Agriculture (2016) Economic Research Service (ERS) Food Availability (Per Capita) Data System, USA.

10 Hooper L, Abdelhamid A, Moore HJ, Douthwaite W, Skeaff CM, et al. (2012) Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomized controlled trials and cohort studies. BMJ 345: e7666.

11 Willett WC (1998) Is dietary fat a major determinant of body fat? Am J Clin Nutr 67: 556S-62S.

12 Heini AF, Weinsier RL (1997) Divergent trends in obesity and fat intake patterns: the American paradox. Am J Med 102: 259-64.

13 Hite AH, Feinman RD, Guzman GE, Satin M, Schoenfeld PA, et al. (2010) In the face of contradictory evidence: Report of the Dietary Guidelines for Americans Committee. Nutrition 26: 915-24.

14 World Health Organization (WHO) Global Database on Body Mass Index an interactive surveillance tool for monitoring nutrition transition, USA.

15 Ministerio de Salud (2009) Second National Risk Factors Survey (ENFR) [Segunda Encuesta Nacional Factores de Riesgo (ENFR)], Argentina.

16 Asterholm IW, Scherer PE (2012) Metabolic jet lag when the fat clock is out of sync. Nat Med 18: 1738-40.

17 Blüher M, Michael MD, Peroni OD, Ueki K, Carter N, et al. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3: 25-38.

18 Chen HC, Jensen DR, Myers HM, Eckel RH, Farese RV Jr (2003) Obesity resistance and enhanced glucose metabolism in mice transplanted with white adipose tissue lacking acyl CoA:diacylglycerol acyltransferase 1. J Clin Invest 111: 1715-22.

19 Silva JE (2003) The thermogenic effect of thyroid hormone and its clinical implications. Ann Intern Med 139: 205-13.

20 Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84: 277-359.

21 Hirsch J, Hudgins LC, Liebel RL, Rosenbaum M (1998) Diet composition and energy balance in humans. Am J Clin Nutr 67: 551S-5S.

22 MacLean PS, Higgins JA, Johnson GC, Fleming-Elder BK, Donahoo WT, et al. (2004) Enhanced metabolic efficiency contributes to weight regain after weight loss in obesity-prone rats. Am J Physiol Regul Integr Comp Physiol 287: R1306-15.

23 Major GC, Alarie FP, Doré J, Tremblay A (2009) Calcium + vitamin D supplementation and fat mass loss in women very low calcium consumers: potential link with a calcium-specific appetite control. Br J Nutr 101:659-63.

24 Shi H, Norman AW, Okamura WH, Sen A, Zemel MB (2002) Synthesis1-25-Dihydroxyvitamin D 3 inhibits uncoupling protein 2 expression in human adipocytes. FASEB J 16: 1808-10.

25 LaKind JS, Goodman M, Nalman DQ (2012) Use of NHANES data to link chemical exposures to chronic diseases: a cautionary tale. PLoS One 7: e51086.

26 Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Human gut microbes associated with obesity. Nature 10.1038/nature4441023a.

27 Westerterp-Plantenga MS, Nieuwenhuizen A, Tomé D, Soenen S, Westerterp KR (2009) Dietary protein, weight loss, and weight maintenance. Annu Rev Nutr 29: 21-41.

28 Murray RK, Granner DK, Mayes PA, Rodwell VW (2003) Harper's Illustrated Biochemistry (26^th Edn) Mc Graw- Hill, USA.

29 U.S. Department of Agriculture and U.S. Department of Health and Human Services (2015) 2015-2020 Dietary Guidelines for Americans (8^th Edn), Washington, USA.

30 Garrow JS, James WPT (1993) Human nutrition and dietetics (9^th Edn) Churchill Livingstone, UK.

31 Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, et al. (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 91: 10878-82.

32 Kawahito, S, Kitahata H, Oshita S (2009) Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroenterol 15: 4137-42.

33 Fontana L, Klein S, Holloszy JO (2010) Effects of long-term calorie restriction and Endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr) 32: 97-108.

34 Saltiel AR (2003) Putting the brakes of insulin signaling. NEJM 349: 2560-62.

35 Melnik B (2012) Leucine signaling in the pathogenesis of type 2 diabetes and obesity. WJDiabetes 3: 38-53.

36 Skeaff CM, Miller J (2009) Dietary Fat and Coronary Heart Disease: Summary of evidence from Prospective Cohort and Randomized Controlled Trials. Ann Nutr Metab 55: 173-201.

37 Spreadbury I (2012) Comparison with ancestral diets suggests dense a celullar carbohydrates promote an inflamatory microbiota, and may be the primary dietary cause of leptin resistance and obesity. Diabetes Metab Syndr Obes 5: 175-189.

38 Mann GV, Spoerry A, Gray M, Jarashow D (1972) Atherosclerosis in the Masai. Am J Epidemiol 95: 26-37.

39 Ho K, Biss K, Mikkelson B, Lewis LA, Taylor CB (1971) The Masai of East Africa: some unique biological characteristics. Arch Pathol 95: 26-37.

40 Taylor BC, Ho Kang-Jey (1971) Studies on the Masai. Am J Clin Nutr 24: 1291-93.

41 Bang HO, Dyerberg J (1980) Lipid metabolism and ischemic heart disease in Greenland Eskimos. Adv Nutr Res 3:1-22.

42 Prior IA, Davidson F, Salmond CE, Czochanska Z (1981) Cholesterol, coconuts, and diet on Polynesian atolls: a natural experiment: the Pukapuka and Tokelau Island studies. Am J Clin Nutr 34: 1552-61.

43 Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, et al. (2006) Effects of a Mediterranea-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 45: 1-11.

44 Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, et al. (2007) Comparison of the Atkins, Zone, Ornish, and LEARN Diets for Change in Weight and Related Risk Factors among Overweight Premenopausal Women. The A TO Z Weight Loss Study: A Randomized Trial. JAMA 297: 969-77.

45 Siri-Tarino PW, Sun Q, Hu FB, Krauss RM (2010) Meta-analysis of prospective cohort Studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 91: 535-46.

46 Astrup A, Dyerberg J, Elwood P, Hermansen K, Hu FB, et al. (2011) The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr 93: 684-8.

47 Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Bälter K, et al. (2009) Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 89: 1425-32.

48 Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, et al. (1986) The diet and 15-year death rate In the Seven Countries Study. Am J Epidemiol 124: 903-1551.

50 Mente A, Koning L, Shannon HS, Anand SS (2009) A Systematic Review of the Evidence Supporting a Causal Link between Dietary Factors and Coronary Heart Disease. Arch Int Med 169: 659-69.

51 Skeaff CM, Miller J (2009) Dietary Fat and Coronary Heart Disease: Summary of evidence from Prospective Cohort and Randomised Controlled Trials. Ann Nutr Metab 55: 173-201.

52 Fats and fatty acids in human nutrition (2010) Report of an expert consultation. Geneve. Food and agriculture organization of the United Nations. FAO food and nutrition paper 91. Rome 55: 173-201.

53 Hulbert AJ, Turner N, Storlien LH, Else PL (2005) Dietary fats and membrane function: implications for metabolism and disease. Biol Rev 80: 155-69.

54 Bonadonna RC, DeFronzo RA (1991) Glucose metabolism in obesity and type II diabetes. Diabete Metab 7: 112-35.

55 Baron AD, Zhu JSH, Weldon H, Maianu L, Garvey WT (1995) Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. J Clin Invest 96: 2792-801.

56 Hawkins M, Barzilai N, Liu R, Hu M,Chen W, et al. (1997) Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest 99: 2173-82.

57 Golks A, Guerini D (2008) The O-linked N-acetilglucosamine modification in cellular signalling and the inmune system. EMBO reports 9: 748–53.

58 Obici S, Rossetti L (2003) Minireview: Nutrient Sensing and the Regulation of Insulin Action and Energy Balance. Endocrinology 144: 5172-8.

59 Unger RH (1995) Lipotoxicity in the pathogenesis of obesitydependent NIDDM: genetic and clinical implications. Diabetes 44: 863-70.

60 Sakai K, Matsumoto K, Nishikawa T, Suefuji M, Nakamaru K, et al. (2003) Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochem Biophys Res Commun 300: 216-22.

61 Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, et al. (2001) Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J Biol Chem 276: 31099-104.

62 Kowluru RA (2003) ExtremelyEffect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52: 818-23.

63 Prabhakar S, Starnes J, Shi S, Lonis B, Tran R (2007) Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol 18: 2945-52.

64 Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-25.

65 Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care 13: 610-30.

66 Randle PJ, Priestman DA, Mistry SC, Halsall A (1994) Glucose fatty acid interactions and the regulation of glucose disposal. J Cell Biochem 55: 1-11.

67 Perseghin G, Ghosh S, Gerow K, Shulman GI (1997) Metabolic defects in lean non diabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46: 1001-9.

68 Saloranta C, Groop L (1996) Interactions between glucose and FFA metabolism in man. Diabetes Metab Rev 12: 15-36.

69 Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10.

70 Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, et al. (2005) Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 54: 3148-53.

71 Bajaj M, Suraamornkul S, Kashyap S, Cusi K, Mandarino L, et al. (2004) Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. J of Clinical Endocrinology and Metabolism 89: 4649-55.

72 Lands B (2008) A critique of paradoxes in current advice on dietary lipids. Progress in Lipid Research 47: 77-106.

73 Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, et al. (2008) The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering : prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168: 1617-24.

74 Hetherington A, Ranson SW (1940) Hypothalamic lessons in the rat. Anat Rec 78: 1-49.

75 Inohue S, Bray GA, Mullen YS (1998) Transplantation of pancreatic beta-cells prevents the development of hyphotalamic obesity in rats. Am J Physiol 235: E 266.

76 Mehran AE, Templeman NM, Brigidi GS, Lim GE, Chu KY, et al. (2012) Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production. Cell Metabolism16: 723-37.

77 Cornaro L (1917) The Art of Living Long. A New and Improved English Version of the Treatise by the Celebrated Venetian Centenarian Luigi Cornaro. Bulter. W.F., Milwaukee.

78 Hursting SD, Dunlap SM (2012) Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue. Ann N Y Acad Sci 1271: 82-7.

79 Godsland IF (2010) Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clinical Science 118: 315-32.

80 Yakar S, Leroith D, Brodt P (2005) The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: lessons from animal models. Cytokine Growth Factor Rev 16: 407-20.

81 Avruch J, Hara K, Lin Y, Liu M, Long X, et al. (2006) Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 25: 6361-72.

82 Rollo CD (2010) Aging and the mammalian regulatory triumvirate. Aging Dis 2: 105-38.

83 Paik JK, Kolipara R, Chu G, Ji H, Xiao Y, et al. (2007) FoxOs are lineage-restricted redundant tumor supressors and regulate endothelial cell homeostasis. Cell 128: 309-23.

84 Carter ME, Brunet A (2007) FOXO transcription factors. Current Biology 17: R114.

85 Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, et al. (2004) The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6: 91-9.

86 Corradetti MN, Inoki K, Bardeesy N, DePinho RA, Guan KL (2004) Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev 18: 1533-8.

87 Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, et al. (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA 101: 3329-35.

88 Carrera AC (2004) TOR signaling in mammals. J Cell Sci 117: 4615-6.

89 Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806.

90 Virkamaki A, Ueki K, Kahn CR (1999) Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103: 931-43.

91 Abdul-Ghani MA, DeFronzo RA (2010) Pathogenesis of Insulin Resistance in Skeletal Muscle. J of Biomedicine and Biotechnology doi:10.1155/2010/476279.

92 Blagosklonny MV (2011) Rapamycin-induced glucose intolerance: Hunger or starvation diabetes. Cell Cycle 10: 4217-24.

93 Keogh A, Richardson M, Ruygrok P, Spratt P, Galbraith A, et al. (2004) Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 110: 2694-700.

94 Rodriguez AE, Granada JF, Rodriguez-Alemparte M, Vigo CF, Delgado J, et al. (2006) Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis The Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study. J Am Coll Cardiol 47: 1522-9.

95 Sarbassov dos D, Ali SM, Sabatini DM (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17: 596-603.

96 Kirkwood TB (2005) Understanding the odd science of aging. Cell 120: 437‐47.

97 Blagosklonny MV (2012) Once again on rapamycin-induced insulin resistance and longevity:despite of or owing to. Aging 4: 350-8.

98 Higgins PB, Bastarrachea RA, Lopez-Alvarenga JC, Garcia-Forey M, Proffitt JM, et al. (2010) Eight week exposure to a high sugar high fat diet results in adiposity gain and alterations in metabolic biomarkers in baboons (Papiohamadryassp.). Cardiovasc Diabetol 9: 71.

99 MacQueen HA, Sadler DA, Moore SA, Daya S, Brown JY, et al. (2007) Deleterious effects of a cafeteria diet on the livers of non-obese rats. Nutr Res 27: 38-47.

100 Aeberli I, Gerber PA, Hochuli M, Kohler S, Haile SR, et al. (2011) Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr 94: 479-85.

101 Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-95.

102 Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, et al. (2002) Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular Carcinoma. Gastroenterology 123: 134-40.

103 Willner IR, Waters B, Patil SR, Reuben A, Morelli J, et al. (2001) Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 96: 2957-61.

104 Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-31.

105 Putnam JJ, Allshouse JE (1999) Food consumption, prices and expenditures, 1970–97. US Department of Agriculture Economic Research Service statistical bulletin no. 965, April 1999. Washington, DC: US Government Printing Office.

106 Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM (2008) Dietary fructose consumption among US children and adults: The Third National Health and Nutrition Examination Survey. Medscape J Med 10: 160.

107 Ervin RB, Ogden CL (2013) Consumption of Added Sugars among U.S. Adults, 2005–2010. NCHS Data Brief 122: 1-8.

108 Casella N (2010) Carrasco Manrique AL, Mesa Milton A. Presencia de jarabe de maiz de alta fructosa en snacks. Actualización en nutrición 11: 185-93.

109 Petersen KF, Laurent D, Yu C, Cline GW, Shulman GI (2001) Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans. Diabetes 50: 1263-8.

110 Mayes PA (1993) Intermediary metabolism of fructose. Am J Clin Nutr 58: 754S–65S.

111 Bantle JP, Laine DC, Castle GW, Thomas JW, Hoogwerf BJ, et al. (1983) Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med 309: 7-12.

112 Havel PJ (1997) Glucose but not fructose infusion increases circulating leptin in proportion to adipose stores in rhesus monkeys. Diabetes 105: 37-8.

113 Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, et al. (2008) Fructose Consumption as a Risk Factor for Non-alcoholic Fatty Liver Disease. J Hepatol 48: 993-9.

114 Hofmann SM, Tschop MH (2009) Dietary sugars: a fat difference. JCI 119: 1089-92.

115 Taylor EN, Curhan GC (2008) Fructose consumption and the risk of kidney stones. Kidney Int 73: 489-96.

116 Choi HK, Curhan G(2008) Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 336: 309-12.

117 Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG, et al. (2009) Hypothesis: Could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 30: 96-116.

118 Nakagawa T, Tuttle KR, Short R, Johnson RJ (2006) Hypothesis: Fructose induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 1: 80-6.

119 Kanellis J, Kang DH (2005) Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 25: 39-42.

120 Alderman MH, Cohen H, Madhavan S, Kivlighn S (1999) Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive patients. Hypertension 34: 144-50.

121 Bergheim I, Weber S, Vos M, Kramer S, Volynets V, et al. (2008) Antibiotics protect against fructose induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatology 48: 983-92.

122 Lustig RH (2013) Fructose: It’s“Alcohol without the Buzz”. Adv Nutr 4: 226-35.

123 Aarsland A, Chinkes D, Wolfe RR (1996) Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest 98: 2008-17.

124 Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, et al. (2009) Consuming fructose sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119: 1322-34.

125 Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, et al. (2007) Nonalcoholic fatty liver disease: Predisposing factors and the role of nutrition. J Nutr Biochem 18: 184-95.

126 Zivkovic AM, German JB, Sanyal AJ (2007) Comparative review of diets for the metabolic syndrome: Implications for nonalcoholic fatty liver disease. Am J Clin Nutr 86: 285-300.

127 Jurgens H, Haass W, Castaneda TR, Schurmann A, Koebnick C, et al. (2005) Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res 13: 1146-56.

128 Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, et al. (2005) Fructose-induced fatty liver disease: Hepatic effects of blood pressure and plasma triglyceride reduction.Hypertension 45: 1012-8.

129 Schwarz JM, Noworolski SM, Lee GA, Wen M, Dyachenko A, et al. (2009) Effects of short-term feeding with high- vs low- fructose isoenergetic diets on hepatic de novo lipogenesis, liver fat content and glucose regulation. Diabetes 1476P.

130 Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, et al. (2009) Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates NEJM 360: 859-73.